[go: up one dir, main page]

AU2001240149A1 - Fibroblast growth factor-like molecules and uses thereof - Google Patents

Fibroblast growth factor-like molecules and uses thereof

Info

Publication number
AU2001240149A1
AU2001240149A1 AU2001240149A AU4014901A AU2001240149A1 AU 2001240149 A1 AU2001240149 A1 AU 2001240149A1 AU 2001240149 A AU2001240149 A AU 2001240149A AU 4014901 A AU4014901 A AU 4014901A AU 2001240149 A1 AU2001240149 A1 AU 2001240149A1
Authority
AU
Australia
Prior art keywords
molecules
growth factor
fibroblast growth
fibroblast
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001240149A
Inventor
Michael B. Bass
Shuqian Jing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AU2001240149A1 publication Critical patent/AU2001240149A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001240149A 2000-03-13 2001-03-13 Fibroblast growth factor-like molecules and uses thereof Abandoned AU2001240149A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18878600P 2000-03-13 2000-03-13
US60188786 2000-03-13
PCT/US2001/008013 WO2001068854A2 (en) 2000-03-13 2001-03-13 Fibroblast growth factor-like molecules and uses thereof

Publications (1)

Publication Number Publication Date
AU2001240149A1 true AU2001240149A1 (en) 2001-09-24

Family

ID=22694517

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001240149A Abandoned AU2001240149A1 (en) 2000-03-13 2001-03-13 Fibroblast growth factor-like molecules and uses thereof

Country Status (3)

Country Link
US (2) US20020037557A1 (en)
AU (1) AU2001240149A1 (en)
WO (1) WO2001068854A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797271B2 (en) 1999-03-25 2004-09-28 Genesis Research & Development Corporation Limited Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
US7083791B2 (en) * 1999-03-25 2006-08-01 Genesis Research & Development Corporation Limited Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
US7253266B2 (en) 1999-07-27 2007-08-07 Curagen Corporation Polypeptides of FGF-CX
US7056885B1 (en) 1999-07-27 2006-06-06 Curagen Corporation Fibroblast growth factor and nucleic acids encoding same
US7291483B2 (en) 1999-07-27 2007-11-06 Curagen Corporation FGF-CX polynucleotide sequences and methods of producing same
EP1273655A4 (en) * 2000-03-30 2004-08-04 Takeda Chemical Industries Ltd PROCESS FOR PRODUCING RECOMBINANT PROTEIN
GB2365869A (en) * 2000-05-30 2002-02-27 Smithkline Beecham Corp SbgFGF-9a polynucleotides and polypeptides
AU2001262934A1 (en) * 2000-06-01 2001-12-11 Eli Lilly And Company Human fgf-20 nucleic acids and polypeptides
US7189693B2 (en) 2000-11-06 2007-03-13 Curagen Corporation Treatment of inflammatory bowel disease using fibroblast growth factor CX polypeptides
US20060094647A1 (en) * 2000-11-06 2006-05-04 Jeffers Michael E Treatment of inflammatory bowel disease using growth factors
US6982250B2 (en) 2000-11-06 2006-01-03 Curagen Corporation Methods of prevention and treatment of inflammatory bowel disease
JP2005500035A (en) * 2001-06-15 2005-01-06 キュラジェン コーポレイション Novel fibroblast growth factor and nucleic acid encoding it
US20070110752A1 (en) * 2002-05-28 2007-05-17 Genesis Research And Development Corporation Limited Fibroblast growth factor receptors and methods for their use
US20060115483A1 (en) * 2002-05-28 2006-06-01 Genesis Research And Development Corporation Limited Fibroblast growth factor receptors and methods for their use
US20050112642A1 (en) * 2002-05-28 2005-05-26 Genesis Research And Development Corporation Limited Fibroblast growth factor receptors and methods for their use
US20050009750A1 (en) * 2003-07-03 2005-01-13 Genesis Research And Development Corporation Limited Fibroblast growth factor receptors and methods for their use
WO2004091534A2 (en) * 2003-04-15 2004-10-28 The Johns Hopkins School Of Medicine Inhibitors of n ethylmaleimide sensitive factor
EP1812460A1 (en) * 2004-11-03 2007-08-01 Curagen Corporation Formulations, methods of production and uses of fgf-20
EP2068909B1 (en) 2007-03-30 2012-04-25 Ambrx, Inc. Modified fgf-21 polypeptides and their uses
LT3412302T (en) 2014-10-24 2021-07-26 Bristol-Myers Squibb Company MODIFIED FGF-21 POLYPEPTIDES AND THEIR USES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6447783B1 (en) * 1995-06-12 2002-09-10 Yeda Research And Development Co., Ltd. Compositions comprising FGF9 and use thereof for stimulating cartilage and bone repair
AU3755900A (en) * 1999-03-15 2000-10-04 Chiron Corporation Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
US7056885B1 (en) * 1999-07-27 2006-06-06 Curagen Corporation Fibroblast growth factor and nucleic acids encoding same
US20020058036A1 (en) * 1999-07-27 2002-05-16 Michael Jeffers Novel fibroblast growth factor and nucleic acids encoding same
CA2388637A1 (en) * 1999-10-22 2001-05-03 Chiron Corporation Human fgf-20 gene and gene expression products

Also Published As

Publication number Publication date
US20020037557A1 (en) 2002-03-28
US7531321B2 (en) 2009-05-12
WO2001068854A3 (en) 2002-03-21
WO2001068854A2 (en) 2001-09-20
US20050208522A1 (en) 2005-09-22

Similar Documents

Publication Publication Date Title
AU5056501A (en) Fibroblast growth factor-like molecules and uses thereof
AU2001240149A1 (en) Fibroblast growth factor-like molecules and uses thereof
AU2002214629A1 (en) Non-metallic bioreactor and uses
AU2002227280A1 (en) Protein modification and maintenance molecules
AU2001282908A1 (en) Bioreactor and bioprocessing technique
AU3924300A (en) Fibroblast growth factor-20
AU2001294549A1 (en) Process and intermediates
HUP0400657A1 (en) Fibroblast growth factors
AU2002220553A1 (en) Bioreactor
AU2002211717A1 (en) Stresscopins and their uses
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AUPQ659800A0 (en) Genetic sequences and uses therefor
AU2001270271A1 (en) Protein modification and maintenance molecules
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU7181101A (en) Novel fibroblast growth factors and nucleic acids encoding same
AU2001236718A1 (en) Bioreactor and related method
AU2001245888A1 (en) Growth factor binding molecules
AU2001271400A1 (en) Bioelastomer nanomachines and biosensors
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2002213259A1 (en) Egf motif protein, egfl6 materials and methods
AUPR968801A0 (en) Improvements in enzyme stability
AUPQ884500A0 (en) Novel therapeutic molecules and uses therefor - III
AU2001257100A1 (en) Nalpha, nomega-dialkyl aminomethylenephosphonic acids and use thereof
AU2001277519A1 (en) Bio-probes and use thereof
MXPA03004675A (en) Transforming growth factor-beta-related molecules and uses thereof.